Adamas Pharmaceuticals
ADMS
#7530
Rank
โ‚ฌ0.32 B
Marketcap
7,19ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,545.55%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.45 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ77.09 Million. In 2020 the company made a revenue of โ‚ฌ65.09 Million an increase over the revenue in the year 2019 that were of โ‚ฌ47.76 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.45 M14.37%
2020โ‚ฌ65.09 M36.28%
2019โ‚ฌ47.76 M60.48%
2018โ‚ฌ29.76 M
2016โ‚ฌ0.5 M-70.15%
2015โ‚ฌ1.67 M-96.57%
2014โ‚ฌ48.82 M-21.45%
2013โ‚ฌ62.15 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚ฌ52.14 B 67,532.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.15 B 72,737.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ37.02 B 47,925.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚ฌ71.41 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.59 B 672.82%๐Ÿ‡บ๐Ÿ‡ธ USA